Pascal Touchon - 01 Mar 2023 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
President and CEO, Director
Signature
/s/ Jeff Kiekhofer, Attorney-in-Fact for Pascal Touchon
Issuer symbol
ATRA
Transactions as of
01 Mar 2023
Net transactions value
$0
Form type
4
Filing time
03 Mar 2023, 16:16:12 UTC
Previous filing
18 Nov 2022
Next filing
06 Mar 2023
SEC
View on sec.gov

Quoteable Key Fact

"Pascal Touchon filed Form 4 for Atara Biotherapeutics, Inc. (ATRA) on 03 Mar 2023."

Quick Takeaways

  • This page summarizes Pascal Touchon's Form 4 filing for Atara Biotherapeutics, Inc. (ATRA).
  • 2 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 03 Mar 2023, 16:16.

What Changed

  • Previous filing in this sequence was filed on 18 Nov 2022.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Award $0 +324,711 +74% $0.000000 766,407 01 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATRA Employee Stock Option (Right to Buy) Award $0 +730,600 $0.000000 730,600 01 Mar 2023 Common Stock 730,600 $3.91 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units vest in 12 equal quarterly installments on each Company Quarterly Vesting Date (as defined below), with the initial installment vesting on May 15, 2023, subject to the reporting person's continuous service. "Company Quarterly Vesting Date" means March 1, May 15, August 15 and November 15 of each year.
F2 1/36th of the shares subject to the stock option vest and become exercisable each month, with the initial installment vesting on April 1, 2023, subject to the reporting person's continuous service.